Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices traded up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 19 points (0.1%) at 16,400 as of Monday, Oct. 20, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 2,294 issues advancing vs. 815 declining with 107 unchanged.

The Diversified Services industry as a whole closed the day up 0.8% versus the S&P 500, which was up 0.9%. Top gainers within the Diversified Services industry included

Wilhelmina International

(

WHLM

), up 1.7%,

Bioanalytical Systems

(

BASI

), up 9.1%,

China Yida

(

CNYD

), up 2.2%,

Onvia

(

ONVI

), up 4.6% and

RLJ Entertainment

(

RLJE

), up 4.0%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

China Yida

(

CNYD

TheStreet Recommends

) is one of the companies that pushed the Diversified Services industry higher today. China Yida was up $0.06 (2.2%) to $2.81 on light volume. Throughout the day, 1,217 shares of China Yida exchanged hands as compared to its average daily volume of 9,500 shares. The stock ranged in a price between $2.80-$2.81 after having opened the day at $2.80 as compared to the previous trading day's close of $2.75.

China Yida Holding, Co., together with its subsidiaries, operates in the tourism and advertisement businesses in the People's Republic of China. The company operates through two segments, Advertisement and Tourism. China Yida has a market cap of $10.8 million and is part of the services sector. Shares are down 4.5% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate China Yida a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates China Yida as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on CNYD go as follows:

  • CHINA YIDA HOLDING CO's earnings per share declined by 26.5% in the most recent quarter compared to the same quarter a year ago. The company has reported a trend of declining earnings per share over the past two years. During the past fiscal year, CHINA YIDA HOLDING CO swung to a loss, reporting -$4.37 versus $0.06 in the prior year.
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Media industry. The net income has significantly decreased by 61.5% when compared to the same quarter one year ago, falling from -$3.12 million to -$5.03 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Media industry and the overall market, CHINA YIDA HOLDING CO's return on equity significantly trails that of both the industry average and the S&P 500.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 60.15%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 26.47% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • CNYD, with its decline in revenue, underperformed when compared the industry average of 9.1%. Since the same quarter one year prior, revenues fell by 10.6%. Weakness in the company's revenue seems to have hurt the bottom line, decreasing earnings per share.

You can view the full analysis from the report here:

China Yida Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

Bioanalytical Systems

(

BASI

) was up $0.20 (9.1%) to $2.40 on average volume. Throughout the day, 10,490 shares of Bioanalytical Systems exchanged hands as compared to its average daily volume of 8,700 shares. The stock ranged in a price between $2.15-$2.45 after having opened the day at $2.27 as compared to the previous trading day's close of $2.20.

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. Bioanalytical Systems has a market cap of $17.8 million and is part of the services sector. Shares are down 18.8% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Bioanalytical Systems a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Bioanalytical Systems as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.

Highlights from TheStreet Ratings analysis on BASI go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Life Sciences Tools & Services industry. The net income has significantly decreased by 62.7% when compared to the same quarter one year ago, falling from $0.58 million to $0.22 million.
  • Net operating cash flow has significantly decreased to $0.21 million or 75.43% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Life Sciences Tools & Services industry and the overall market, BIOANALYTICAL SYSTEMS INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • BIOANALYTICAL SYSTEMS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, BIOANALYTICAL SYSTEMS INC turned its bottom line around by earning $0.09 versus -$0.87 in the prior year.
  • 39.46% is the gross profit margin for BIOANALYTICAL SYSTEMS INC which we consider to be strong. Regardless of BASI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 3.56% trails the industry average.

You can view the full analysis from the report here:

Bioanalytical Systems Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Wilhelmina International

(

WHLM

) was another company that pushed the Diversified Services industry higher today. Wilhelmina International was up $0.10 (1.7%) to $6.00 on light volume. Throughout the day, 275 shares of Wilhelmina International exchanged hands as compared to its average daily volume of 2,300 shares. The stock ranged in a price between $5.66-$6.00 after having opened the day at $5.66 as compared to the previous trading day's close of $5.90.

Wilhelmina International has a market cap of $34.6 million and is part of the services sector. Shares are down 1.7% year-to-date as of the close of trading on Friday.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.